Examining how gender-affirming therapy affects the molecular profiles of immune cells of trans men reveals how hormones underpin immune responses. Read the paper: Immune system adaptation during ...

The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2 ...

one of the largest yet to examine how gender-affirming hormone therapy (GAHT) affects the immune system over time. The results provide much-needed insight and could help to explain why men tend to ...

This study was very small, comparing drug levels in eight trans women versus four cis men. All participants were observed taking PrEP each day for eight days (directly observed therapy). There were as ...

Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

Menopausal women are at greater risk of insulin resistance as a result of declining estrogen levels. Previous studies evaluating the potential benefits of hormone therapy on insulin resistance have ...

Compounded hormones have been defined as ... Addition of DHEA to Menopausal Therapy DHEA levels decrease with age in women and men; and although DHEA may be added to menopausal therapy to improve ...

Transgender people in the custody in the Idaho Department of Corrections can get hormone therapy, for now, according a ...

Menopausal women are at greater risk of insulin resistance as a result of declining estrogen levels. Previous studies evaluating the potential benefits of hormone therapy on insulin resistance have ...

The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2 ...